`CORPORATION,(“WEST”) BUSINESS WIRE ARTICLES ON WESTLAWNEXT
`
`I swear that
`
`1, Mynameis Jennifer Rock and I have been employed by West Publishing Corporation in the
`area which acquires newsarticles for inclusion on Westlaw for 13 years.
`
`The following information is based on my knowledge of West’s customary and routine
`business practices during the time I have been employed.
`
`West obtains newsarticles under license from Business Wire for inclusion on Westlaw to
`permit authorized subscribers to access thesearticles.
`
`West includes the text of the newsarticles on Westlaw as they are received from Business
`Wire.
`
`The three articles attached to this affidavit are accurate copiesofthe articles as they appear
`on Westlaw as of today’s date.
`
`These three articles, to the best of my knowledge andbelief, would have been available to
`authorized Westlaw subscribers as of the following times:
`
`a. Business Wirearticle titled “BG-12 Psoriasis Study Meets Primary Endpoint; Oral
`Compound Also Being Studied for MS in PhaseII Trial” was available on April 7,
`2005 at 07:15:03 a.m. CT.
`b. Business Wirearticle titled “Phase II Study of Oral Compound BG-12 Meets Primary
`Endpoint in Multiple Sclerosis” was available on January 9, 2006 at 07:49:24 a.m.
`CT.
`c. Business Wire article titled “Oral Compound BG-12 Achieves Primary Endpoint in
`Phase II Study of Relapsing-Remitting Multiple Sclerosis; Treatment with BG-12
`Ledto Statistically Significant Reductions in MRI measures” wasavailable on May
`30, 2006 at 09:13:05 a.m. CT.
`
`lL affirm that the statements contained herein are known by meor believed by meto be true and
`correct.
`
`7/3/2018
`
`X Jennifer Rock
`
`Jennifer Rock
`
`Signed by: U0067718
`
`Sworn by Jennifer Rock, West Publishing Corporation, 610 Opperman Drive, Eagan, MN 55123
`
`Sawai (IPR2019-00789), Ex. 1055, p. 001
`
`